254 related articles for article (PubMed ID: 35593989)
1. The α5-nAChR/PD-L1 axis facilitates lung adenocarcinoma cell migration and invasion.
Zhu P; Kang G; Jiao Y; Gui C; Fan H; Li X; Jia Y; Zhang L; Ma X
Hum Cell; 2022 Jul; 35(4):1207-1218. PubMed ID: 35593989
[TBL] [Abstract][Full Text] [Related]
2. Alpha5 nicotinic acetylcholine receptor mediated immune escape of lung adenocarcinoma via STAT3/Jab1-PD-L1 signalling.
Zhu P; Jin Z; Kang G; Jia Y; Liu D; Zhang Q; Guo F; Jia Y; Jiao Y; Li J; Sun H; Ma X
Cell Commun Signal; 2022 Aug; 20(1):121. PubMed ID: 35971127
[TBL] [Abstract][Full Text] [Related]
3. PLEK2 mediates metastasis and invasion via α5-nAChR activation in nicotine-induced lung adenocarcinoma.
Li Q; Li J; Wang J; Wang J; Lu T; Jia Y; Sun H; Ma X
Mol Carcinog; 2024 Feb; 63(2):253-265. PubMed ID: 37921560
[TBL] [Abstract][Full Text] [Related]
4. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
[TBL] [Abstract][Full Text] [Related]
5. α5-nAChR/STAT3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape.
Kang G; Jiao Y; Pan P; Fan H; Li Q; Li X; Li J; Wang Y; Jia Y; Wang J; Sun H; Ma X
Carcinogenesis; 2023 Dec; 44(10-11):773-784. PubMed ID: 37681453
[TBL] [Abstract][Full Text] [Related]
6. The role of α5-nicotinic acetylcholine receptor/NLRP3 signaling pathway in lung adenocarcinoma cell proliferation and migration.
Jia Y; Zhang Q; Liu Z; Pan P; Jia Y; Zhu P; Jiao Y; Kang G; Ma X
Toxicology; 2022 Mar; 469():153120. PubMed ID: 35131329
[TBL] [Abstract][Full Text] [Related]
7. α5-nAChR associated with Ly6E modulates cell migration via TGF-β1/Smad signaling in non-small cell lung cancer.
Zhang Q; Jia Y; Pan P; Zhang X; Jia Y; Zhu P; Chen X; Jiao Y; Kang G; Zhang L; Ma X
Carcinogenesis; 2022 May; 43(4):393-404. PubMed ID: 34994389
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholine promotes chronic stress-induced lung adenocarcinoma progression via α5-nAChR/FHIT pathway.
Jiao Y; Kang G; Pan P; Fan H; Li Q; Li X; Li J; Wang Y; Jia Y; Zhang L; Sun H; Ma X
Cell Mol Life Sci; 2023 Apr; 80(5):119. PubMed ID: 37029227
[TBL] [Abstract][Full Text] [Related]
9. α5-nAChR and survivin: Two potential biological targets in lung adenocarcinoma.
Zhang Y; Sun Y; Jia Y; Zhang Q; Zhu P; Ma X
J Cell Physiol; 2021 Mar; 236(3):1787-1797. PubMed ID: 33196129
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Nicotine Activates EGFR Signaling via α5-nAChR and Promotes Lung Adenocarcinoma Progression.
Wang ML; Hsu YF; Liu CH; Kuo YL; Chen YC; Yeh YC; Ho HL; Wu YC; Chou TY; Wu CW
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957649
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal activation of α5-nAChR and STAT3 in nicotine-induced human lung cancer cell proliferation.
Zhang Y; Jia Y; Li P; Li H; Xiao D; Wang Y; Ma X
J Genet Genomics; 2017 Jul; 44(7):355-362. PubMed ID: 28750889
[TBL] [Abstract][Full Text] [Related]
12. BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma.
Mao CG; Jiang SS; Wang XY; Tao SL; Jiang B; Mao CY; Yang YL; Hu ZY; Long T; Jin H; Tan QY; Huang Y; Deng B
Int J Biol Sci; 2021; 17(10):2461-2475. PubMed ID: 34326687
[No Abstract] [Full Text] [Related]
13. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W
Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098
[TBL] [Abstract][Full Text] [Related]
14. Serum exosomal miR-16-5p functions as a tumor inhibitor and a new biomarker for PD-L1 inhibitor-dependent immunotherapy in lung adenocarcinoma by regulating PD-L1 expression.
Chen HL; Luo YP; Lin MW; Peng XX; Liu ML; Wang YC; Li SJ; Yang DH; Yang ZX
Cancer Med; 2022 Jul; 11(13):2627-2643. PubMed ID: 35347894
[TBL] [Abstract][Full Text] [Related]
15. Trametinib sensitizes KRAS-mutant lung adenocarcinoma tumors to PD-1/PD-L1 axis blockade via Id1 downregulation.
Puyalto A; Rodríguez-Remírez M; López I; Macaya I; Guruceaga E; Olmedo M; Vilalta-Lacarra A; Welch C; Sandiego S; Vicent S; Valencia K; Calvo A; Pio R; Raez LE; Rolfo C; Ajona D; Gil-Bazo I
Mol Cancer; 2024 Apr; 23(1):78. PubMed ID: 38643157
[TBL] [Abstract][Full Text] [Related]
16. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
17. Chemotherapy enhances programmed cell death 1/ligand 1 expression via TGF-β induced epithelial mesenchymal transition in non-small cell lung cancer.
Funaki S; Shintani Y; Kawamura T; Kanzaki R; Minami M; Okumura M
Oncol Rep; 2017 Oct; 38(4):2277-2284. PubMed ID: 28849209
[TBL] [Abstract][Full Text] [Related]
18. The α9 Nicotinic Acetylcholine Receptor Mediates Nicotine-Induced PD-L1 Expression and Regulates Melanoma Cell Proliferation and Migration.
Nguyen HD; Liao YC; Ho YS; Chen LC; Chang HW; Cheng TC; Liu D; Lee WR; Shen SC; Wu CH; Tu SH
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31835799
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SGMS1-AS1 regulates lung adenocarcinoma cell proliferation, migration, invasion, and EMT progression via miR-106a-5p/MYLI9 axis.
Liu T; Yang C; Wang W; Liu C
Thorac Cancer; 2021 Jul; 12(14):2104-2112. PubMed ID: 34061466
[TBL] [Abstract][Full Text] [Related]
20. Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624-mediated PD-L1 pathway.
Jin G; Ma M; Yang C; Zhen L; Feng M
Thorac Cancer; 2023 Aug; 14(24):2493-2503. PubMed ID: 37423604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
